Wiley - Immune Dysfunction and Immunotherapy in Heart Disease

Current heart failure therapeutics often focus on managing symptoms but fail to address the underlying causes, leaving mortality rates at approximately 50% within five years. This book by Wiley provides a necessary shift in perspective by proposing a new mechanism for heart failure: immune mediated cardiac remodelling for cardiac dysfunction. Through a deep look at how the immune system influences heart health, this text explores the potential for immunotherapy to change patient outcomes. The content is guided by an expert editorial team, including Ronald Watson, an immunologist with a decade of research in immune dysfunction and a patent for heart disease immunotherapy, and Douglas Larson, a specialist in cardiac transplantation. This resource is designed for medical professionals and researchers looking to understand the connection between immune regulation and cardiac disease to improve long-term treatment strategies.